CUAMC
RPTX

China Universal Asset Management Company’s Repare Therapeutics RPTX Stock Holding History

China Universal Asset Management Company’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,079
Closed -$13K – 475
2023
Q3 		$13K Buy
1,079
+527
+95% +$5.44K ﹤0.01% 333
2023
Q2 		$5.84K Sell
552
-18
-3% -$185 ﹤0.01% 357
2023
Q1 		$5.61K Buy
570
+144
+34% +$1.65K ﹤0.01% 355
2022
Q4 		$6.27K Buy
426
+33
+8% +$494 ﹤0.01% 269
2022
Q3 		$5K Buy
+393
New +$5.06K ﹤0.01% 276

Other funds holding RPTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

China Universal Asset Management Company's RPTX Position: Q4 2023 in Review

China Universal Asset Management Company sold out of Repare Therapeutics (RPTX) in Q4 2023, closing a stake of 1,079 shares — an estimated $13K sold.

China Universal Asset Management Company first reported a position in RPTX in Q3 2022 and held it in 5 quarters. The position peaked at $13K in Q3 2023. 69 funds tracked by Wall St. Rank hold RPTX as of Q4 2023.

  • China Universal Asset Management Company reported no remaining Repare Therapeutics position as of Q4 2023 after selling out during the quarter.
  • China Universal Asset Management Company sold 1,079 Repare Therapeutics shares in Q4 2023, an estimated $13K.
  • China Universal Asset Management Company first reported a position in Repare Therapeutics in Q3 2022 and held it in 5 quarters.
  • China Universal Asset Management Company's Repare Therapeutics position peaked at $13K in Q3 2023.
  • 69 funds tracked by Wall St. Rank held Repare Therapeutics as of Q4 2023.

Based on China Universal Asset Management Company's 13F filing for Q4 2023, filed 24 Jan 2024.